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Prevalence of Methicillin Resistant Staphylococcus Aureus (MRSA) 
and Antimicrobial Susceptibility Patterns at a Private Hospital in 
Sana'a, Yemen. 
 
Background:Methicillin Resistant Staphylococcus Aureus (MRSA) strains are 
common causes of nosocomial infections and are associated with increased morbidity 
and mortality. In addition, the antibiotic resistance for MRSA is a major concern in 
clinical practice.  
Objective:To study the prevalence and the antimicrobial susceptibility pattern of 
MRSA isolates from patients in a private hospital. 
Methods: The study was performed ata private hospital in Sana’a, Yemen. All the 
patients' samples from January, 2017 to December, 2017 were included. All isolates 
from inpatients’ clinical specimens (mainly respiratory secretion, pus, urine, and 
blood) were collected and standard isolation procedures were applied to all the 
samples.The records were taken from the microbiology department. Antibiotic 
susceptibility testing was done by Kirby Bauer's Disc diffusion technique, following 
the national committee for clinical laboratory standards. The antimicrobial 
susceptibility patterns of all the MRSA strains were studied against several 
antibiotics. 
Results: A total of 2079 samples were gathered during the study period. Among 
them, 199 strains of staphylococcus aureus were isolated.A majority of 
staphylococcus aureus isolates were from pus specimen (n=81/199; 40.7%).MRSA 
prevalence among the patients was 17.6 % (n=35/199; 17.6). Highest proportion of 
MRSA was in ICU and surgical departments about 29% of all MRSA isolates.A 
majority of MRSAisolates were from sputum specimen(n=18/35; 51.4%) 
The study findings showed that MRSA isolates had the highest frequency of 
resistant(100%) to levofloxacin and amoxicillin/clavulinic acid, followed by 
ciprofloxacin 97%, gentamicin and ampicillin/ sulbactam 94 %, cefuroxime 91 %, 
moxifloxacin 76%, erythromycin 71.5%, clindamycin 70.5%, and imipenem 55%. 
The highest frequency of sensitivity (100%) was observed with linezolide, 
vancomycin, and trimethoprim/sulfamethoxazole. 
Conclusion: MRSA isolates were highly susceptible to newer drugs such as linezolid 
and to vancomycin which is not a commonly prescribed drug due to the higher 
nephrotoxic antibiotic. A more careful monitoring for use of broad-spectrum 
antibiotics should be instituted. 
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1. Introduction: 
 Staphylococcus aureus is one of the most important pathogens affecting 
humans.Penicillin is the drug of choice to treat infections caused by staphylococcus 
aureus.Because of the penicillin was commonly prescribed drugs, the prevalence of 
penicillin resistant strains increased, especially in hospitals
(1)
.MRSA was first 
described in 1961. It was reported after one year of introduction of methicillin. 
Recently, it was defined as one of the most important nosocomial pathogens.New 
studies suggest that the infection due to MRSA is not only hospital-acquired but 
community acquired as well
(2)
.Also MRSA has become a major public health problem 
worldwide 
(3)
.Some large outbreaks of MRSA have been documented from different 
regions of the world, where it had caused severe infections including septicemia, 
endocarditis and meningitis
(4)
. 
A study by Dickinson in England and Wales has approved an increase in the death 
rateof MRSA infection 
(5)
.The risk factors that increase in MRSAprevalence are 
antibiotics abuse, prolonged hospitalization,intravascular instrumentation and 
hospitalization in an intensive care unit.There is significant variation in prevalence of 
clinical infections among units, hospitals and countries 
(4)
. MRSA is of seriousconcern 
because of resistance to many other antimicrobials that are commonly used in 
hospitals.Another importantelementwas that emergence of resistance to vancomycin, 
although at a low level has been documented 
(6)
.Significantly, the Netherlands and 
countries in the Scandinavian region, had maintained low rates of MRSA infectiondue 
to strict infection control practices
(7)
. The problem of MRSA continues to increase 
and the rising colonization rates lead to the increasing of infection rates in the public 
and in hospitals. This can increase hospital stays and greater costsof the health care 
system
(8)
.  
Appropriate selection of empiric antibioticsfor infections, dependingonlocal 
circulating pathogens, can lead to good patient outcomes. So, epidemiologic 
information collected through ongoing surveillance is important to support clinicians 
and infection control committees to prevent and treat infection
(7)
.The hospitals of 
different sizes were facing the problem of MRSA. In addition, the problem of MRSA 
appears to be increasing regardless the size of hospital and its control measures for 
MRSA
(8)
. The aim of the present study is the detection of MRSA from various clinical 
departments at a local private hospital in Sana'a, Yemen and determining their 
susceptibility to some antimicrobial agents. 
2. Method: 
The current retrospective study based on electronic laboratory records of 
staphylococcus aureus isolates and MRSA isolates from clinical specimens analyzed 
at microbiology laboratory of university of sciences and technology (UST) hospital in 
Sana’a, Yemen.  
 The records were taken from the microbiology department. Staphylococcus strains 
were identified based on Gram's stain morphology, colony characteristics, and 
biochemicalidentification tests. All isolates were identified as S. aureus according to 
standard methods
(9)
. A total of 2079 isolates were collected from the hospitalized 
patients in hospital of UST from January 2017 to September 2017. These isolates 
were obtained through conventional clinically oriented ordered cultures. From 2079 
isolates, a total of 199 isolates were S. aureus strains. Methicillin resistance was 
determined using methicillin screening. 
All isolates were from inpatients’ clinical specimens (mainly respiratory secretion, 
pus, urine, and blood) and Standard isolation procedures were applied to all the 
samples. 
Antibiotic susceptibility testing was done by Kirby Bauer's Disc diffusion technique, 
followingClinical & Laboratory Standards Institute (CLSI)
(9)
. The antimicrobial 
susceptibility patterns of all the MRSA strains were determined against the following 
antibiotics: vancomycin, linezolide, imipenem, levofloxacin, ciprofloxacin, Co-
Trimoxzole, Erythromycin, amoxicillin/ clavulinic Acid, cefuroxime, doxycycline, 
clindamycin, ampicillin/ sulbactam, gentamicin, moxifloxacin, and Lincomycin.  
Full ethical clearance was obtained from the qualified authorities who approved the 
study design. All data were analyzed using SPSS Statistics 21. Data was presented in 
tables and graphs. All data were analyzed using SPSS Statistics 21. Data was 
presented in tables and graphs. 
4. Results: 
The figure 1 showed highest numbers of staphylococcus aureus were obtained from 
pus (n=81/199; 40.7%) and least from urine (n=11/199; 5.5%).In this study, Overall 
MRSA prevalence was 17.6 % (n=35/199; 17.6). 
 
Figure 1. Distribution of S. aureus according to sample types 
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The study results showed that the most of the  MRSA isolatesprevalence in age group 
between 46 to 60 years about 12(34%), followed by the age more than 60 years in 
second rank about 8 (23%), and finally the age between 1 to 15 or years only about 
2(6%). 
 
 
 
Figure 2. Distribution of MRSA isolates according to age group. 
  
The figure 3 showed that the most 
of the MRSA isolateswere in male about 29(83%), whereas the female participants 
only about 6(17%). 
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Figure 3. Distribution of MRSA isolates according to gender. 
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According to the study findings, ICU and surgical departments had the same and most 
prevalence of MRSA about 10(29%), followed by the medical and laboratory 
departments with rank about 6 (17%), and finally the neurological department only 
about 3(8 %). 
Figure 4. Distribution of MRSA isolates according to hospital departments. 
The figure 5 showed that more than half of MRSA isolates from sputum culture about 
18(51.4%), followed by the wound swab culture about 12 (34.3%), and finally blood 
culture only about 2(5.7%). 
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Figure 5. Distribution of MRSA isolates according to sample test. 
 
In this study, the most of medication that had resistance to MRSA test were about 12 
drugs (80%), whereas the medication that sensitive to MRSA test about 3 drugs 
(20%). Also the study results showed that MRSA isolates were resistant to 
levofloxacin 100 %, amoxicillin/clavulinic acid100%, moxifloxacin 76 %, gentamicin 
94 %, clindamycin 70.5%, ciprofloxacin 97%, cfuroxime 91 % erythromycin 
71.5%,and ampicillin/ sulbactam 94%. The highest frequency of sensitivity (100 %) 
was observed with trimethoprim/sulfamethoxazole, linezolide, and vancomycin(table 
1). 
Table 1. The antibiotic susceptibility pattern for MRSA isolates 
Antibiotic Expected 
options 
Response Antibiotic Expected 
options 
Response 
F % F % 
Imipenem 
 
S 10 30% Moxifloxacin 
 
S 0 00% 
R 18 55% R 25 76% 
I 5 15% I 8 24% 
Amoxicillin / 
Clavulinic 
Acid 
 
S 0 00% Gentamicin 
 
S 2 6% 
R 33 100% R 32 94% 
I 0 00% I 0 00% 
Ampicillin/ 
Sulbactam 
 
S 1 6% Clindamycin 
 
S 10 29.5
% 
R 16 94% R 24 70.5
% 
I 0 00% I 0 00% 
Cefuroxime 
 
S 3 9% Levofloxacin 
 
S 0 00% 
R 31 91% R 35 100
% 
I 0 00% I 0 00% 
Erythromycin S 10 28.5% Trimethoprim/ S 35 100
  sulfamethoxaz
ole  
% 
R 25 71.5% R 0 00% 
I 0 00% I 0 0.0% 
Ciprofloxacin 
 
S 1 3% Linezolid 
 
S 31 100
% 
R 33 97% R 0 00% 
I 0 00% I 0 00% 
Doxycycline  S 2 5.8% Vancomycin 
 
S 35 100
% 
R 31 91.2% R 0 00% 
I 1 3% I 0 00% 
  
The table (2) showed there were no statistical significant relationship between the 
usage of vancomycin and linezolid age group (P value = 0.74, 0.44). 
Table 2. The sensitivity pattern of vancomycin and Linezolidewithin age group. 
Age group Vancomycin The level of 
(P value) S R I 
1 - 15 years 2 0 0  
 
0.74 
16 - 30 years 6 0 0 
31 - 45 years 7 0 0 
46 - 60 years 11 0 0 
more than 60 years 8 0 0 
 linezolid  
1 - 15 years 2 0 0 
0.44 
16 - 30 years 6 0 0 
31 - 45 years 7 0 0 
46 - 60 years 10 0 0 
more than 60 years 6 0 0 
 
The table (3) showed there were no statistical significant relationship between the 
sensitivity pattern of vancomycin and linezolid hospital department (P-value = 0.63, 
0.35). 
Table 3. The sensitivity pattern of vancomycin and linezolide within hospital 
department. 
Hospital Department vancomycin The level of 
(P value) S R I 
Medical department 6 0 0  
 
0.63 
Surgical department 10 0 0 
ICU department 9 0 0 
Neurological diseases 3 0 0 
Laboratory department 6 0 0 
 Hospital Department linezolid  
Medical department 5 0 0 
0.35 
Surgical department 10 0 0 
ICU department 8 0 0 
Neurological diseases 2 0 0 
Laboratory department 6 0 0 
 
Also the study findings showed that there was no statistical significant relationship 
between the sensitivity pattern of vancomycin and linezolide and sample type (P 
value= 0.80, 0.23). 
Table 3. The sensitivity pattern of vancomycin and linezolide within sample type. 
Sample Type Vancomycin P-value 
S R I 
Sputum culture 17 0 0  
 
0.80 
Blood culture 2 0 0 
Pus for culture 3 0 0 
wound swab for culture 12 0 0 
 linezolid  
Sputum culture 14 0 0 
0.23 
Blood culture 2 0 0 
Pus for culture 3 0 0 
Wound swab for culture 12 0 0 
 
4. Discussion: 
Recently, the prevalence of MRSA hassteadily increased worldwide 
(4)
. In addition, 
the antimicrobial susceptibility pattern of MRSA strains should be described. In our 
study, most S. aureus strains (n=81/199; 40.7%) were isolated from pus 
specimen.This is consistent with a previous study done in Nairobi
(10)
. In a study done 
to determine the antimicrobial susceptibility pattern of S. aureus strains isolated from 
hospitalized patients in Iran, most of the isolates were from blood specimens 
(29%)
(11)
. Another study done on prevalence and antibiotic susceptibility pattern of S. 
aureus from clinical isolates in Nigeria showed a majority of the isolates were from 
urine specimens (76%) 
(12)
.The high number of S. aureus isolated in pus may be 
attributed to exposure of wounds which makes them more prone to infections and 
poor hygiene. 
In this study, overall MRSA prevalence was 17.6 % (n=35/199; 17.6). This 
prevalence was lower than in previous studies that reported 31.5% 
(13)
 and 46.3% 
(14)
. 
This difference could be due to various interventions during the study period such as 
infection control and appropriate antibiotic usage
(14, 15)
. 
 Also MRSA prevalence was higher in studies done in two private hospitals in Nairobi, 
Kenya, which showed a 3.8% prevalence
(16)
. In addition, a study in Eritrea reported 
0.03% of prevalence in Dutch hospitals 
(17)
. This approved there is high variance of 
MRSA prevalence from different countries. The low prevalence of MRSA in private 
hospitals could be attributed to better infection controls
(14)
. 
According to current study results, majority of MRSA was isolated from sputum 
specimens, 18/35 (51.4%). In contrast to study findings in Nigeria
(6)
, and Iran
(11)
 
showed different specimens were predominant. This variation in prevalence may be 
because of several factors like healthcare facilities available in the particular hospital, 
implementation and monitoring of infection control committee, rationale antibiotic 
usage which varies from hospital to hospital
(14,15)
. 
In this study, 100% of MRSA isolates were sensitive to vancomycin. This finding is 
similar to a study done on antimicrobial susceptibility of MRSA in hospitalized 
patients in Iran, two hospitals in India and two private hospitals in Kenya showed 
100% susceptibility to vancomycin 
(17, 18, 10)
. On other hand, studies done in 
Iran
(19)
which showed 5% of the MRSA isolates were resistant to vancomycin and in a 
tertiary care hospital in India
(20)
 and pediatrics and neonatal intensive care patients at 
Nairobi
(6)
which respectively showed 3.5 and 1% resistance to vancomycin among 
MRSA. Recently, many antibiotics with anti-MRSA activity were introduced to the 
market, some of which are available in Yemen. Linezolid is among these agents 
which is not widely available and it is not in use in many Yemeni hospitals including 
the setting of this study. In the present study, 100% of MRSA isolates were sensitive 
to linezolid. Garcia et al. have reported the first clinical outbreak of linezolid resistant 
S. aureus (LRSA) from a tertiary teaching university hospital in Madrid, Spain 
(21)
. In 
their article they reported 12 patients with LRSA from which 6 patients died (with one 
death ascribed to LRSA infection). In the last two decades prevalence of MRSA has 
steadily increased worldwide. Therefore, they stated that this increase was associated 
with nosocomial transmission and extensive use of this antibiotic
(22)
. 
In this study, the results showed that MRSA isolates were resistant to levofloxacin100 
%, amoxicillin/clavulinic acid100%, moxifloxacin 76%, gentamicin 94%, 
clindamycin 70.5%, ciprofloxacin 97%, cefuroxime 91% erythromycin 
71.5%,ampicillin/ sulbactam 94%, and imipenem55%. The highest frequency of 
sensitivity (100 %) was observed with trimethoprim/sulfamethoxazole, linezolide, and 
vancomycin. Multidrug-resistance madethe treatment of MRSA more difficult. This 
may be due to dispensing antibiotics without prescription and inappropriate selection 
of antibiotics for infections as empirical treatment worldwide. Also the use of broad-
spectrum antibiotics for treating infections such as imipenem may beincrease the rate 
of MRSA and other resistant pathogens, so a more careful monitoring of antibiotics 
should be instituted.Vancomycin is the universally accepted drug ofchoice. We found 
 all MRSA isolates to be susceptible to vancomycin. Similar results have been reported 
by other authors
(23,24)
.  
Resistant to quinolones (Levofloxacin, ciprofloxacin, and moxifloxacin) was high 
(100, 97%, and 76%; respectively) in the present study. In a previous study 
(25)
, the 
resistant rate was also high (87.5%), but another study 
(26)
conducted in 2003, reported 
the resistant rate of ciprofloxacin to be only 32.6%. The rapid emergence of 
quinolones was probably due to the indiscriminate empirical use of these drugs.An 
important finding of the present study was that the MRSA cases from ICU accounted 
for 17.6 % of all cases. Our finding was in agreement with the findings of Dominique 
et al. 
(27)
from Switzerland. Also slightly higher than study conducted in 2003 from 
Nebal, reported the MRSA cases from ICU was only 10% from all MRSA cases
(37)
. A 
European study on prevalence of MRSA infection on samples from intensive care, 
estimated close to 65%
(28)
. In the present study,the low prevalence of MRSA, which 
included clinical samples from all hospital wards, illustrated the efficacy of relatively 
good infection control practice in the study setting. Also maximum resistance was 
seen with ampicillin-sulbactam, amoxicillin-clavulanicand gentamicin (table 3). 
Similar results were obtained in a previous study 
(29)
. In addition, resistance was also 
seen with cefuroxime (91%), doxycyclin (91.2%), and erythromycin (71.5%). 
Gentamicin is a most commonly used drug, because of its low cost and synergistic 
activity with beta-lactam antibiotics. In the present study,94% of gentamicin 
resistance was seen, which was slightly higher than a previous study
(30)
. Most 
common reason for multidrug resistant MRSA is indiscriminate use of antibiotics 
without drug sensitivity testing which may be due to lack of advanced laboratory 
facilities or negligence on the part of medical practitioners or patients poor economic 
status. Also this is due to the fact that MRSA is often multidrugresistant
(6)
. 
Although vancomycin seems to be the only antimicrobial agent which showed 100% 
sensitivity and may be used as the drug of choice for treating multidrug-resistant 
MRSA infections, vancomycin is not a commonlyprescribed drug, which is almost 
due to the higher nephrotoxic antibiotic and its unavailability in many parts of the 
country.The control of MRSA transmission seems to be the only hope to complete 
eradication of MRSA. The most effective way to control MRSA is good hand hygiene 
along with environmental cleaning of hospital roomsto reduce nosocomial rates of 
infection, 
(7)
.The results of current study showed thattherewere highly susceptible to 
newer drugs such as linezolid.This finding differs from a study done by Arianpoor et 
al. in Iran which showed 5.5% of MRSA isolates were resistant to linezolid
(19)
. 
5. Conclusion and recommendations: 
The present study showed a low level prevalence of MRSA. AlsoMRSAisolates were 
highly susceptible to newer drugs such as linezolid and to vancomycin which is not a 
commonly prescribed drug due to the higher nephrotoxic antibiotic.Also this study 
 showed that ICU and surgicalwards had the highest proportion of MRSA isolates of 
hospital departments. Information from this study may be used in future as abaseline 
for follow-up to the susceptibility trend of variousdrugs to be used for the treatment of 
S. aureus infections.Routine screening of MRSA and regular studiesshould be 
conducted to predict the trend of MRSA. 
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